Subject: Re: mmi Illness, cytokines and depression

Reactivation of Illnesses

----- for personal use only -------


Date: Sun, 25 Aug 2002 16:59:40 EDT

My daughter developed many Lyme disease symptoms after being vaccinated for rubella at the age of 14. [I was told her childhood vaccination for rubella had not taken and it was important for her to be revaccinated .]   At the time we were living in Fairfield, Ct..  Her symptoms did not all come at once but, the various symptoms, did start following the vaccination. The symptoms were numerous, stomach problems, vision problems, swollen painful knees, extremely easy bruising leading to her gym teacher questioning her about her homelife, a ruptured Baker's cyst, change for the worse in her school work and grades, to name a few. The specialists I took her to could never find the cause of the particular symptom exhibited at the time.   I started to believe she was "faking it" and just did not want to attend class.

I have since learned that my daughter does hae Lyme disease and I have also learned that.the infection may have been activated by the vaccination.

Had I known what I know now, my daughter would not have received the rubella vaccine.  I understand that about 1/3 of young women vaccinated for rubella develop symptoms of chronic arthritis.


Boston Lyme Disease Foundation Symposium 1996:

Dr. Cosaro, Westchester County, New York pediatrician:

"I'd like to comment  from the point of view of pediatrics.

This is something I do see on a regular basis.  If you have latent Lyme disease,
that's Lyme disease unrecognized and you receive the standard immunizations,
your disease can be reactivated instead of quieted.
In the rheumatological literature it is well known that if you have active juvenile rheumatoid
arthritis, you should not receive any of the standard immunizations DPT,
measles, flu shot because these are known to reactivate the arthritis phase of
that disease.

The same thing happens in Lyme disease and I've seen a lot of
patients who we clearly can state that their symptoms started within 2 weeks
of receiving the measles, mumps, german measles shots, for instance, which is
mandatory for 5 year olds in New York before they start kindergarden.

I see a number of children present with arthritis, children whose symptoms began
within two weeks of receiving that immunization."

Immunization: Theory versus Reality

by Neil Miller

"According to Dr. Robert Gallo, the chief AIDS researcher at the
National Cancer Institute. the use of live vaccines such as that used for
smallpox can '  activate ' a dormant infection such as HIV. In fact, the
greatest spread of HIV infection coincides with the most intense  and  recent
smallpox vaccination campaigns. .."

More References

Guillain-Barre syndrome after measles, mumps, and rubella vaccine

Lancet Jan 1 1994 Vol 343 [1pg]

Polyneuropathy Following Rubella Immunization

Am J Dis Child 1974 Vol 127 [5pgs]

Postpartum Rubella Immunization: Association with Development of Prolonged Arthritis, Neurological Sequelae, and Chronic Rubella Viremia

THE JOURNAL OF INFECTIOUS DISEASES 1985 vol 152 no 3) [7pgs]

Risk of Aseptic Meningitis after Measles, Mumps , and Rubella Vaccine in UK Children

Lancet 1993 Vol 341 Pgs. 979 [4pgs]

Neurological disorders Following Live Measles-Virus Vaccination

JAMA March 1973, Vol 223 No 13) [4pgs]

Severe Hypersensitivity or Intolerance Reactions To Measles Vaccine In Six Children

ALLERGY 1980 35) [7]

Pathogenesis of Encephalitis Occurring with Vaccination , Variola and Measles

Arch of Neurology and Psychiatry 1938 Vol 39 [8pgs]

Aseptic Meningitis after Vaccination Against Measles and Mumps

Pediatr Infec Dis J 1989 8 pg 302-308) [7pgs]

Optic Neuritis Complicating Measles, Mumps, and Rubella Vaccination

American Journal of Opthalmology 1978 :86 [4pgs.]

Measles Vaccine Associated Encephalitis in Canada

Lancet Sept. 1983 [2pgs]

Guillain -Barre Syndrome Following Administration of Live Measles Vaccine

Amer J of Med 1976 Vol 60 [3pgs]

In a 19 month old girl and a 16 month old girl the gullian barre
syndrome developed within a week after they received, respectively, live
measles-rubella vaccine and live measles vaccine. The older child was
immune to rubella at the time of vaccination, but both girls
demonstrated a primary measles antibody response. Serum obtained during
the acute and convalescent stages from the younger child was tested for
antibodies against the herpes virus, epstein barre virus, cytomeglovirus
and varicella -zoster and found to be negative. the author goes on to
state vaccine and wild strains can in the pathological process lead to
demyelinzation. These two cases again emphasize the need to carefully
document the neurological diseases which follow infections with live
virus vaccines.

Aseptic Meningitis as a Complication of Mumps Vaccination

Ped Infec Dis J 1991 Vol 10 No 3) [5pgs]

A Prefecture-wide Survey of Mumps Meningitis Associated with Measles, Mumps and Rubella Vaccine

Infec Dis J 1991 Vol 10 pg 204-209)

Mumps Meningitis and Measles, mumps and rubella vaccine

(this is dealing with the Urabe strain mumps)
Lancet Sept 1992 pg. 786 [1pg]

A Prefecture -Wide Survey of Mumps Meningitis Associated With Measles, Mumps and Rubella Vaccine

Pediatri Infect Dis J 1991;10 [6pgs]

Mumps Meningitis Following Measles, Mumps, and Rubella Immunization

Lancet July 1989 [1pg]

Guillain -Barre Syndrome occurrence following combined mumps- rubella vaccine

Am J Dis Child Vol 125 1973 [2pgs]

Mumps Vaccines and Meningitis / Heterogeneous Mumps Vaccine

(more on Urabe strain vaccine)
Lancet Vol 340 1992 [2pgs.]

" In 84% of multiple sclerosis patients we were able to demonstrate intrathecal antibody production against measles, rubella or mumps virus............"
(This quote is from the first of the following abstracts.
I find it interesting because these  three viruses are also included in one shot for vaccinations. What are these antibodies doing in the spinal fluid and being used as a marker for MS?
Does anyone know?

Heller J, Holzer G, Schimrigk K. Immunological differentiation between neuroborreliosis and multiple sclerosis. J Neurol. 1990 Dec;237(8):465-70.
Heller J, Holzer G, Schimrigk K. [ELISA for specifying oligoclonal bands of isoelectric focusing of cerebrospinal fluid in patients with neuroborreliosis and multiple sclerosis], Nervenarzt. 1990 Apr;61(4):248-9. German.

----------------------- Internet Header --------------------------------
Received: from ( [])
        by (8.9.3/8.9.3/SUN-1.14) with ESMTP id RAA12036
        for <>; Sun, 25 Aug 2002 17:02:52 -0400 (EDT)
Received: (from majordomo@localhost)
        by (8.11.6/8.11.6) id g7PKtZN27107
        for mmi-list.kraken; Sun, 25 Aug 2002 15:55:35 -0500
Received: from ( [])
        by (8.11.6/8.11.6) with ESMTP id g7PKtXd27102
        for <>; Sun, 25 Aug 2002 15:55:33 -0500
Received: from ( [])
        by (8.11.6/8.11.6) with ESMTP id g7PKxqx31020
        for <>; Sun, 25 Aug 2002 15:59:52 -0500
Received: from
        by (mail_out_v33.5.) id n.157.130beba3 (3310)
         for <>; Sun, 25 Aug 2002 16:59:40 -0400 (EDT)
Message-ID: <>
Date: Sun, 25 Aug 2002 16:59:40 EDT
Subject: Re: mmi Illness, cytokines and depression
MIME-Version: 1.0
Content-Type: text/plain; charset="US-ASCII"
Content-Transfer-Encoding: 7bit
X-Mailer: AOL 5.0 for Windows sub 139
Precedence: bulk

Looks like the United States is not the only country with

conflict of interest problems.


"............   Documents produced by two Department of Health committees
responsible for reviewing the safety and efficacy of the vaccine, the Committee on Safety of
Medicines (CSM) and the Joint Committee on Vaccination and Immunisation,
reveal that significant numbers of members have links with manufacturers of
the MMR jab...."


Parents unhappy with MMR safety experts' links to drug firms
By Lorraine Fraser, Medical Correspondent
(Filed: 25/08/2002)

Concerns are growing over the links between doctors advising the Government
on the safety of the MMR triple vaccine and the pharmaceutical companies
that make it.

Documents produced by two Department of Health committees responsible for
reviewing the safety and efficacy of the vaccine, the Committee on Safety of
Medicines (CSM) and the Joint Committee on Vaccination and Immunisation,
reveal that significant numbers of members have links with manufacturers of
the MMR jab.

Fifteen of the 36 members of the CSM have declared personal or non-personal
links with companies cited in a class action being brought by parents who
believe that the measles, mumps and rubella triple vaccine has harmed their

Six committee members have personal shareholdings and/or hold consultancy
posts with MMR manufacturer GlaxoSmithKline and nine have a past or present
association, such as receiving research funding from companies involved. Two
members have declared interests in both categories.

Among the 20 members of the vaccination and immunisation committee, two have
declared consultancy work, again with Glaxo, and six have recorded
non-personal interests relating to relevant companies. One member has
interests in both categories.

Although there is no evidence that their opinions on MMR have been
influenced by their links with the pharmaceutical firms, the extent of them
has caused disquiet.

David Thrower, a parent who has campaigned for more research into MMR, said:
"The tolerance of potential conflicts of interest in the medical
establishment has reached an extraordinary level, both in terms of the scale
of the interests involved and the apparent complete disinterest of central
government in this issue.

"Yet it is particularly critical when considering the safety of medical
products that the people making those judgments don't have any conflict of
interest, indirect or direct.

"You have to ask yourself, do the conflicts of interest overwhelm the
scientific considerations of safety."

It emerged yesterday that Phillip Minor, a professor in charge of a
department promised a government grant to conduct a study crucial to the MMR
debate, is being paid to advise legal firms acting for GlaxoSmithKline on
the safety of vaccines.

The director of the institute, Stephen Inglis, who is also a member of the
vaccination and immunisation committee, where he has declared non-personal
interests involving Glaxo, has defended the specialists.

He said that any suggestion that the work would not be carried out
objectively was "insulting".

A spokesman for the Department of Health said a code of practice barred
committee members from participating in any decision on a product if they
had declared an interest in the company making it.

"Anyone who declares any sort of interest in the pharmaceutical industry
cannot play a part in any decision relating to those companies and has to
leave the room when the subject arises," he said.

Parents' groups are uncomfortable with the situation, however. Richard
Miles, who coordinates Autism Research Campaign for Health, said: "We are
very concerned to ensure that this study does not turn out to be a

version: 28. August 2002
URL of this Page
Home of this Server